Skip to content

AdaptHealth AHCO Free cash flow

Free cash flow at other companies

CVS Health logo
CVS HealthCVS
$3.4B-10.8%
Cardinal Health logo
Cardinal HealthCAH
$1.68B-40.0%
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
-$8.68M+62.6%
ResMed logo
ResMedRMD
$520.48M-6.7%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Encompass Health Corporation logo
Encompass Health CorporationEHC

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%
EPS (diluted)-$0.12-140%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%

Valuation

See full
Market cap$1.36B+10.6%
Enterprise value$3.32B+1.7%
P/S0.4×0.0×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Calculated from AdaptHealth’s reported figures.

The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdaptHealth's free cash flow?
AdaptHealth (AHCO) reported free cash flow of -$27.49M in Q1 2026.
How has AdaptHealth's free cash flow changed year-over-year?
AdaptHealth's free cash flow decreased by 47296.6% year-over-year, from -$58K to -$27.49M.
What is the long-term trend for AdaptHealth's free cash flow?
Over 3 years (2022 to 2025), AdaptHealth's free cash flow has grown at a 132.1% compound annual growth rate (CAGR), from -$17.56M to $219.38M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.